John J. Condemi

Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy

Nicola A. Hanania, Oral Alpan, Daniel L. Hamilos et al. · Annals of Internal Medicine · 2011 · 550 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

A double‐blind, randomized, placebo‐controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca

Dianne Petrone, John J. Condemi, Rose Fife et al. · Arthritis & Rheumatism · 2002 · 279 citations

Medicine, Ophthalmology, Pharmacotherapy +16

Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial

John A. Smith, Michael M. Kitt, Alyn H. Morice et al. · The Lancet Respiratory Medicine · 2020 · 224 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Procainamide-induced lupus erythematosus

Stephen E. Blomgren, John J. Condemi, John H. Vaughan · The American Journal of Medicine · 1972 · 220 citations

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma

William W. Busse, Paul Chervinsky, John J. Condemi et al. · Journal of Allergy and Clinical Immunology · 1998 · 185 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13